midazolam hydrochloride / Generic mfg. |
NCT00866853: TMC435-TiDP16-C107: This Study Measures the (Possible) Influence of TMC435 on the Activity of a Selected Set of Drug-degrading Proteins by Measuring the Blood Levels of Drugs That Have Been Taken Together With TMC435 and That Are Known to be Specifically Degraded by These Drug-degrading Proteins. |
|
|
| Completed | 1 | 16 | Europe | TMC435 | Tibotec Pharmaceuticals, Ireland | Hepatitis C, Viruses | 07/09 | 07/09 | | |
NCT01060566: Study of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770 |
|
|
| Completed | 1 | 24 | US | VX-770 | Vertex Pharmaceuticals Incorporated | Cystic Fibrosis | 03/10 | 04/10 | | |
NCT01405612: Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam in Healthy Volunteers |
|
|
| Completed | 1 | 14 | Europe | Midazolam, Ulimorelin, TZP101 | Norgine | Digestive System Disorders | 07/11 | 07/11 | | |
NCT01489943: A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects |
|
|
| Completed | 1 | 24 | US | GSK1605786 500 mg, Midazolam 3 mg, Pioglitazone 15 mg, Omeprazole 40 mg, Rosuvastatin 10 mg | GlaxoSmithKline | Crohn's Disease | 11/11 | 11/11 | | |
NCT00996879: Study to Assess the Effect of BMS-791325 on the Pharmacokinetics of Midazolam in Healthy Subjects |
|
|
| Completed | 1 | 48 | US | Midazolam, BMS-791325 | Bristol-Myers Squibb | Hepatitis C | 09/13 | 09/13 | | |
NCT01525628: Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients |
|
|
| Completed | 1 | 72 | US, Canada, Europe | midazolam, BI 201335, tenofovir, caffeine, tolbutamide, pegylated interferon, BI 207127, ribavirin | Boehringer Ingelheim | Hepatitis C, Chronic | 12/13 | 10/14 | | |
NCT02045966: Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects |
|
|
| Completed | 1 | 16 | US | Cocktail, DCV 3DAA FDC, BMS-791325 | Bristol-Myers Squibb | Hepatitis C | 04/14 | 04/14 | | |